Restasis Ophthalmic Drops, Emulsion 0.05pct Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • Weekly Ad

Restasis: Ophthalmic drops, emulsion (0.05%)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png
Restasis 0.05% Ophth Emulsion
Drug Image file default-drug-image.png
Restasis 0.05% Ophth Emulsion

What is this Medicine?

CYCLOSPORINE (SYE kloe spor een) eye drops are used to increase tear production in patients who have dry eyes due to eye inflammation.

CVS Pharmacy Patient Statistics for Restasis: Ophthalmic drops, emulsion(0.05%)
Generic vs. Brand Name Usage*
*Brand contains same active ingredient but may not represent FDA-approved generic equivalent
Usage By Strength
In-Depth Information
Select a Medication

Restasis 0.05% Ophthalmic Emulsion

NDC: 000239163
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Xerophthalmia

Storage Information
Store between 59 to 77 degrees F
Restasis 0.05% Ophthalmic Emulsion

Reported Side Effects for Restasis 0.05% Ophthalmic Emulsion

Angioedema Incidence:
<3.0%*
Severity: SEVERE
Onset: RAPID
Hives Incidence:
<3.0%*
Severity: MILD
Onset: RAPID
Secondary Malignancy Incidence:
<6.0%*
Severity: MODERATE
Onset: DELAYED
Red Eyes Incidence:
1.0-5.0%*
Severity: MODERATE
Onset: EARLY
Shortness Of Breath Incidence:
1.0-6.5%*
Severity: MODERATE
Onset: EARLY
Eye Pain Incidence:
1.0-5.0%*
Severity: MILD
Onset: EARLY
Itchy Eyes Incidence:
1.0-5.0%*
Severity: MILD
Onset: RAPID
Blurred Vision Incidence:
1.0-5.0%*
Severity: MODERATE
Onset: EARLY
Epiphora Incidence:
1.0-5.0%*
Severity: MODERATE
Onset: EARLY
Foreign Body Sensation Incidence:
1.0-5.0%*
Severity: MILD
Onset: RAPID
Eye Drainage Incidence:
1.0-5.0%*
Severity: MILD
Onset: DELAYED
Eye Irritation Incidence:
17.0%*
Severity: MILD
Onset: RAPID
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

SECOND Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

THIRD Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Lactation

Compatible - This drug is generally safe to take by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Restasis

We want to help you stay educated about the medications you are taking. View other
patient's observations and share your own.

Be sure to consult your health care provider before taking any medications. Other
patient's comments should not be considered medical advice or health care provider
recommendations.